The study team reported that exposure of the fission yeast Schizosaccharomyces pombe to electron transport chain (ETC) Complex III inhibitors lowered the effectiveness of azole antifungals. They observed this effect whether the ETC inhibitor was given before or at the same time as the azole. Short exposures produced measurable decreases in azole potency. Longer or repeated exposure further attenuated growth inhibition by azoles. The authors framed these findings in the context of widespread agricultural use of azole-based ergosterol inhibitors together with ETC-targeting compounds.
Data indicated that ETC inhibition led to mitochondrial dysfunction in the yeast model. That dysfunction was associated with accumulation of reactive oxygen species (ROS), and the study team observed activation of canonical oxidative stress response pathways downstream of ROS. Those stress responses correlated with reduced azole potency. The authors reported mechanistic links rather than only phenotypic correlations: ROS accumulation after ETC inhibition appeared to trigger cellular responses that blunt the antifungal action of ergosterol-targeting agents. The preprint describes these intracellular responses in S. pombe but does not include clinical isolates or in vivo mammalian infection models.
Azole fungicides are commonly deployed both in clinical settings and extensively in agriculture. The authors noted that azole-based ergosterol inhibitors are widely used on crops alongside compounds that inhibit ETC Complex III. Their experimental results raise a concern: combining these classes in the environment could select for reduced azole sensitivity through the same mitochondrial-ROS pathway described in yeast. The preprint does not provide epidemiologic field data linking agricultural fungicide combinations to clinical resistance trends; instead, investigators extrapolated mechanistic findings from a laboratory model to suggest possible consequences for pathogenic fungi. The study team did reference related responses reported in some pathogenic species, indicating a plausible, though not yet proven, pathway for agricultural practice to influence clinical antifungal resistance.
The authors concluded that current use of specific fungicide combinations warrants re-evaluation to help preserve both clinical and agricultural effectiveness of azoles. They recommended reconsidering simultaneous or sequential application of azole ergosterol inhibitors with ETC Complex III inhibitors. The manuscript is a preprint and has not been certified by peer review; the authors declared no competing interests. The report lists funding sources supporting the work.
Limitations were described in the scope of the data. The experiments were conducted in a laboratory model organism, Schizosaccharomyces pombe, and the source did not report direct field or clinical transmission data linking agricultural use patterns to population-level azole resistance in human pathogens. The preprint also did not report details of any in vivo mammalian studies, dose–response relationships in pathogens of clinical interest, or longitudinal surveillance outcomes. Those gaps mean the mechanistic link between ETC inhibition, ROS-driven stress responses, and emergent resistance in pathogenic fungi remains a hypothesis supported by model-system data rather than a proven pathway in humans or crops.
Unanswered questions the authors flagged include whether the same mitochondrial-ROS signaling cascade operates identically in major fungal pathogens under field or clinical exposure conditions, and what specific application practices (timing, dose, environmental persistence) would most strongly select for reduced azole sensitivity. The study team did not provide regulatory milestones or timelines for reassessment; they recommended policy and stewardship discussions informed by further mechanistic and field-level studies. The final practical step they proposed was targeted re-evaluation of fungicide combinations to prevent inadvertent promotion of azole resistance in the wider fungal community.
Note: this article is a preprint and has not undergone peer review. The findings are mechanistic and model-based; translation into agricultural policy or clinical guidance will require confirmatory studies in pathogens, field surveillance data, and peer-reviewed validation.